Skip to content

Role of Intensive BP Control in Stroke Outcome : An Indian Perspective

Study of Three Month Outcome in Patients with Acute Stroke based On Intensive vs Standard Blood Pressure Control In a Tertiary Care Centre - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062377
Enrollment
50
Registered
2024-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G819- Hemiplegia, unspecified

Interventions

Intervention1: Three Month Outcome in Patients with Acute Stroke on Intensive Blood Pressure Control: Maintaining Systolic Blood Pressure between 110-120 mm Hg and Diastolic Blood Pressure between 75-

Sponsors

Pt B D Sharma PGIMS Rohtak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Hypertensive patients (Known or newly detected) with acute stroke, both hemorrhagic and ischemic

Exclusion criteria

Exclusion criteria: 1. Patients with traumatic brain injury 2. Presence of hemorrhagic complications during endovascular therapy 3. Severe or fatal comorbidities that would confound the outcome of the study (e.g. Malignancy that would affect mortality of the patients enrolled ) 4. A pre-existing stroke disability defined by a modified Rankin Scale (mRS) score greater than two

Design outcomes

Primary

MeasureTime frame
1.Incidence of recurrent stroke 2.Functional outcomes (measured by MRS scale) after 3 months 3. All Cause and CVA related Mortality Timepoint: 3 months

Secondary

MeasureTime frame
1. Extent of control of Hypertensive Status by various anti hypertensive regimens 3. Compliance to anti-hypertensive therapyTimepoint: 3 months

Countries

India

Contacts

Public ContactDr Angshuman Mukherjee

Pt B.D. Sharma, PGIMS , Rohtak

surekhadabla@yahoo.co.in9416291276

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026